SpeeDx STIs Reached Record Highs, Then COVID-19 Hit. Test Makers Now Ponder What's Next Premium As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests. SARS-CoV-2 Delta Variant PCR Could Help Surveillance Efforts, Developers Say Premium Labs and commercial developers have created simple, inexpensive PCR assays for the SARS-CoV-2 Delta variant that they say could help surveillance efforts. SpeeDx Gets Regulatory Approval in Australia for COVID-19 Molecular Test Kit The assay detects two regions of the SARS-CoV-2 virus that the firm claims are unaltered in all currently circulating variants. New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More SpeeDx, MolGen Partner for COVID-19 Testing The agreement connects SpeeDx chemistry with MolGen's equipment for a fully integrated, high-throughput sample-to-answer workflow, the firms said. May 11, 2021 CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC Mar 18, 2021 SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey Nov 17, 2020 SpeeDx Expanding MDx Portfolio With Respiratory Virus Host-Response Test Premium Nov 9, 2020 SpeeDx Partners With Nepean Hospital on Respiratory Viral Illness Test Jun 16, 2020 Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests Feb 11, 2020 SpeeDx Raises Additional $15M Jan 13, 2020 SpeeDx, LabCorp Will Codevelop MDx Tests Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Sep 6, 2019 SpeeDx Mycoplasma Genitalium Resistance Test on Cepheid System Receives CE-IVD Sep 6, 2019 As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow Premium Aug 5, 2019 SpeeDx Raises $15M in Equity Investment Jul 15, 2019 SpeeDx Gets Health Canada Approval for Mycoplasma Genitalium ID, Drug Resistance Test Jun 24, 2019 SpeeDx, GSK Sign Test Supply, Development Deal Apr 15, 2019 Cepheid Outlines Assay Improvements, Xpert Cartridge Partnering Program at ECCMID Premium Mar 18, 2019 SpeeDx Signs Distributor Deals in Middle East Jan 23, 2019 SpeeDx Signs Distribution Deals in Finland, Italy Dec 6, 2018 SpeeDx Gets CE-IVD Mark for Antibiotic-Resistant Gonorrhea MDx Nov 8, 2018 SpeeDx Signs Distributions Deals Across Europe Jun 26, 2018 SpeeDx Pursues Clinical Trials Ahead of Anticipated FDA Clearance for M. Genitalium Assay Premium Apr 23, 2018 SpeeDx Signs UK, Ireland Distribution Deal Load More Breaking News Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation Lifespan Linked to Lower Protein Synthesis Gene Expression Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds The Scan Sensor to Spot SARS-CoV-2 Exposure Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register. Watching BA.2 A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says. Vermont Weighs Genetic Discrimination Bill VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information. PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.